These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 19765117)

  • 1. Intravenous thrombolysis is feasible and safe in multiethnic Asian stroke patients in Singapore.
    Sharma VK; Tsivgoulis G; Tan JH; Ong BK; Chan BP; Teoh HL
    Int J Stroke; 2009 Oct; 4(5):320-1. PubMed ID: 19765117
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombolysis for stroke: policy should be based on science, and not on politics, money or fear of malpractice.
    Hoffman JR
    Emerg Med Australas; 2006 Jun; 18(3):215-8. PubMed ID: 16712529
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemorrhagic complications of thrombolytic therapy.
    Vujković Z; Racić D; Miljković S; Dajić V
    Med Pregl; 2012; 65(1-2):9-12. PubMed ID: 22452232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
    Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
    Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolysis for stroke in the over 80s.
    Ford GA
    Age Ageing; 2004 Mar; 33(2):95-7. PubMed ID: 14960420
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety and outcome after thrombolysis in stroke patients with mild symptoms.
    Köhrmann M; Nowe T; Huttner HB; Engelhorn T; Struffert T; Kollmar R; Saake M; Doerfler A; Schwab S; Schellinger PD
    Cerebrovasc Dis; 2009; 27(2):160-6. PubMed ID: 19092237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
    Hermann A; Dzialowski I; Koch R; Gahn G
    J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The smoking-thrombolysis paradox and acute ischemic stroke.
    Fisher M
    Neurology; 2006 Feb; 66(3):458; author reply 458. PubMed ID: 16476964
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravenous recombinant tissue plasminogen activator for acute stroke in Poland: an analysis based on the Safe Implementation of Thrombolysis in Stroke (SITS) Registry.
    Kobayashi A; Czlonkowska A; Ahmed N; Romanowicz S; Glonek M; Nyka WM; Opala G; Wahlgren N;
    Acta Neurol Scand; 2010 Oct; 122(4):229-36. PubMed ID: 19919643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subarachnoid hemorrhage--a rare complication after intravenous thrombolysis in an ischemic stroke patient.
    Chou CL; Lin YJ; Po HL; Chang CK
    Am J Emerg Med; 2010 Oct; 28(8):984.e1-3. PubMed ID: 20825835
    [No Abstract]   [Full Text] [Related]  

  • 11. Telephonic guidance of systemic thrombolysis in acute ischemic stroke: safety outcome in rural hospitals.
    Vaishnav AG; Pettigrew LC; Ryan S
    Clin Neurol Neurosurg; 2008 May; 110(5):451-4. PubMed ID: 18353532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of Iranian stroke patients eligible for intravenous thrombolysis with tPA.
    Ghandehari K; Zahed AP; Taheri M; Abbasi M; Gorjestani S; Ahmadi AM; Nahayati MA
    Int J Stroke; 2009 Aug; 4(4):236. PubMed ID: 19689746
    [No Abstract]   [Full Text] [Related]  

  • 13. Intravenous thrombolysis based on diffusion-weighted imaging and fluid-attenuated inversion recovery mismatch in acute stroke patients with unknown onset time.
    Aoki J; Kimura K; Iguchi Y; Shibazaki K; Iwanaga T; Watanabe M; Kobayashi K; Sakai K; Sakamoto Y
    Cerebrovasc Dis; 2011; 31(5):435-41. PubMed ID: 21346348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation assessment of risk scores to predict postthrombolysis intracerebral haemorrhage.
    Cucchiara B; Kasner S; Tanne D; Levine S; Demchuk A; Messe S; Sansing L; Lees K; Lyden P;
    Int J Stroke; 2011 Apr; 6(2):109-11. PubMed ID: 21371270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risks and benefits of thrombolysis in the elderly.
    Asdaghi N; Butcher KS; Hill MD
    Int J Stroke; 2012 Feb; 7(2):142-9. PubMed ID: 22264367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic thrombolysis in clinical practice: what have we learned after the Safe Implementation of Thrombolysis in Stroke Monitoring Study?
    Wahlgren N
    Cerebrovasc Dis; 2009; 27 Suppl 1():168-76. PubMed ID: 19342848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombolytic therapy in cerebral infarction].
    Varga V; Waje-Andreassen U; Naess H; Lundstadsveen MT; Thomassen L
    Tidsskr Nor Laegeforen; 2009 Nov; 129(21):2214-7. PubMed ID: 19898567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolysis, community hospitals, and primary stroke center.
    Jeng JS
    Acta Neurol Taiwan; 2009 Mar; 18(1):1-2. PubMed ID: 19537567
    [No Abstract]   [Full Text] [Related]  

  • 19. Mortality of stroke patients treated with thrombolysis: analysis of nationwide inpatient sample.
    Flaherty ML; Kissela B; Khatri P
    Neurology; 2007 Feb; 68(9):710-1; author reply 711. PubMed ID: 17328117
    [No Abstract]   [Full Text] [Related]  

  • 20. Mortality of stroke patients treated with thrombolysis: analysis of nationwide inpatient sample.
    Kurth T; Heuschmann PU; Walker AM; Berger K
    Neurology; 2007 Feb; 68(9):710; author reply 711. PubMed ID: 17325289
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.